Regentis Biomaterials Ltd.
$2.96
▲
3.67%
2026-04-21 09:08:01
www.regentis.co.il
ASE: RGNT
Explore Regentis Biomaterials Ltd. stock price, valuation, financial statements, dividend history, analyst estimates, and long-term business fundamentals on StockSifting.
Market Cap
—
Current Price
$2.96
52W High / Low
$8.35 / $2.8
Stock P/E
—
Book Value
$0.92
Dividend Yield
—
ROCE
-181.68%
ROE
75.07%
Face Value
—
EPS
$-24.16
Exp Qtr EPS
—
Sector
Healthcare
Industry
Medical Instruments & Supplies
Employees
—
Beta
—
Debt / Equity
25.23
Current Ratio
2.65
Quick Ratio
2.65
Forward P/E
—
Price / Sales
—
Enterprise Value
$9.88 M
EV / EBITDA
—
EV / Revenue
—
Rating
None
Target Price
$10
EPS Forecast (FY)
—
Pros
- Healthy return on equity.
- Balance sheet leverage appears manageable.
- Short-term liquidity looks comfortable.
Cons
- Capital efficiency is modest.
- Operating margin is thin.
- Net margin is relatively low.
Sift Stocks
| S.No. | Name | Price | P.E. | Market Cap | Div Yld % | ROCE | ROE | 52Week High/ Low | Book Value |
|---|---|---|---|---|---|---|---|---|---|
| 1. | Avantor, Inc. | $8.5 | — | $5.76 B | — | 5.22% | -9.2% | $16.17 / $7.26 | $8.24 |
| 2. | West Pharmaceutical Services, Inc. | $274.81 | 40.51 | $19.81 B | 0.33% | 17.6% | 16.86% | $322.34 / $193.05 | $44.11 |
| 3. | GlucoTrack, Inc. | $0.78 | — | $1.55 M | — | -524.96% | 381.2% | $15.9 / $0.62 | $3.06 |
| 4. | Zentek Ltd. | $0.5 | — | $73.33 M | — | -64.39% | -56.64% | $2.5 / $0.63 | $0.08 |
| 5. | LeMaitre Vascular, Inc. | $115 | 44.97 | $2.6 B | 0.87% | 11.72% | 15.8% | $118.01 / $78.01 | $17.28 |
| 6. | Nyxoah SA | $3.23 | — | $121.16 M | — | -119.32% | -1.11% | $8.87 / $2.35 | $1.33 |
| 7. | OraSure Technologies, Inc. | $3.19 | — | $221.2 M | — | -18.75% | -18.3% | $3.82 / $2.08 | $4.84 |
Quarterly Results
Figures shown in M / B
| Sales |
|---|
| Operating Profit |
| Net Profit |
| EPS in Rs |
Profit & Loss
Figures shown in M / B
| 2025 | 2024 | 2023 | 2022 | |
|---|---|---|---|---|
| Sales | 0 M | 0 M | 0 M | 0 M |
| Operating Profit | -8.62 M | 0.93 M | -1.93 M | -1.41 M |
| Net Profit | -13.65 M | 4.8 M | -4.13 M | -1.45 M |
| EPS in Rs | -2.64 | 0.93 | -0.8 | -0.28 |
Balance Sheet
Figures shown in M / B
| 2025 | 2024 | 2023 | 2022 | |
|---|---|---|---|---|
| Total Assets | 7.62 M | 0.48 M | 0.36 M | 1.72 M |
| Total Liabilities | 2.87 M | 41.59 M | 46.27 M | 43.78 M |
| Equity | 4.74 M | -41.1 M | -45.91 M | -42.06 M |
| Current Assets | 7.62 M | 0.48 M | 0.36 M | 1.72 M |
| Current Liabilities | 2.87 M | 6.49 M | 3.14 M | 2.61 M |
Cash Flow
Last available yearly cash flow history
| 2025 | 2024 | 2023 | 2022 | |
|---|---|---|---|---|
| Operating CF | -1.38 M | -0.64 M | -1.22 M | -1.5 M |
| Investing CF | — | — | — | — |
| Financing CF | 8.52 M | 0.53 M | 0.33 M | 0 M |
| Free CF | -1.38 M | -0.64 M | -1.22 M | -1.5 M |
| Capex | — | — | — | — |
5Y Margin & Growth History
Last 5 year derived history from yfinance annual statements
| 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|
| Revenue Growth % | — | — | — | — |
| Earnings Growth % | 216.19% | -185.16% | — | — |
| Profit Margin % | — | — | — | — |
| Operating Margin % | — | — | — | — |
| Gross Margin % | — | — | — | — |
| EBITDA Margin % | — | — | — | — |
Dividend & Split History
Latest dividend and stock split events stored from yfinance
Dividend History
No dividend history available.
Stock Splits
No stock split history available.